|
||
|
KeyNeurotek AG
Download PDF Members: KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment of acute and chronic neurodegenerative disorders of the Central Nervous System (e.g. stroke and Alzheimer disease), the company merges superior expertise in neurobiology, preclinical and clinical drug development, medicinal chemistry and in silico/wet chemistry. KeyNeurotek has established efficient platform technologies for a tissue-based and disease-related functional screening ex and in vivo in order to catalyze the identification and development of highly promising drug candidates. KeyNeurotek's exclusive and HTS-compatible TELOMICSTM ex vivo Robotics represents the first setup for tissue-based high content screening world-wide and the technological basis of our approach to drug development.
This page has been viewed 242 times since April 2007, the link to the organisation's website has been followed 61 times Recent Search Terms used to find this page: keyneurotek huntington | A Keyneurotek | keyneurotek | keyneurotek | keyneurotek | keyneurotek ag | infokeyneurotek.de | . Search for more companies in Magdeburg This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for KeyNeurotek AG | ||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|